Safety and Tolerability of Antiretroviral (Triumeq) in Patients With Amyotrophic Lateral Sclerosis (ALS).
Clinical trial NCT02868580 · COMPLETED
Trial details
- NCT number
- NCT02868580
- Sponsor
- Neuroscience Trials Australia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2017-12-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.